Clinical Trial Update: Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 evaluation of 18F-DCFBC PSMA-based PET imaging for detecting metastatic prostate cancer; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-08-20